Mecamylamine Hydrochloride may be available in the countries listed below.
Mecamylamine Hydrochloride (BANM) is known as Mecamylamine in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
Ezith may be available in the countries listed below.
Azithromycin is reported as an ingredient of Ezith in the following countries:
International Drug Name Search
Doxorubicin is for intravenous (IV) use only and should only be given under the supervision of a doctor experienced in the use of cancer chemotherapy agents. If Doxorubicin accidentally leaks into surrounding tissue, the skin and/or muscle may be severely damaged. Notify your doctor immediately if redness, pain, or swelling at or around the injection site occur.
Doxorubicin may cause severe and possibly life-threatening heart problems (eg, heart failure). These problems may occur during therapy or sometimes months to years after receiving Doxorubicin. In some cases, heart problems are irreversible. The risk may be increased if you are using certain medicines that may affect heart function (eg, trastuzumab), or have a history of heart problems, radiation treatment to the chest area, or previous therapy with other anthracyclines (eg, epirubicin). The risk of developing heart problems varies depending on your dose and condition, although it can occur at any dose whether or not you are at risk. Notify your doctor immediately if you develop cough; fast, slow, or irregular heartbeat; shortness of breath; sudden, unexplained weight gain; or swelling of the hands, ankles, or feet.
Another type of cancer (acute myelogenous leukemia [AML]) and a certain blood problem (myelodysplastic syndrome [MDS]) have been reported in patients treated with anthracyclines, including Doxorubicin. The risk varies depending on your dose and other medicines and/or radiation therapy. Discuss any questions or concerns with your doctor.
Doxorubicin may cause bone marrow suppression. Notify your doctor immediately if you develop easy bruising or bleeding, unusual tiredness or weakness, or signs of an infection (eg, fever, chills, persistent sore throat).
Tell your doctor if you have liver problems because your dose will have to be decreased. Your doctor will closely monitor you while you are using Doxorubicin.
Treating various types of cancer.
Doxorubicin is an antineoplastic antibiotic. It works by killing cancer cells.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Doxorubicin. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Doxorubicin. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Doxorubicin may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Doxorubicin as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Doxorubicin.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea; hair loss; loss of appetite; nausea; stomach pain; tiredness; weakness; weight changes.
Severe allergic reactions (rash; hives; itching; difficulty breathing; dizziness; flushed face; tightness in the chest; swelling of the mouth, face, lips, or tongue); absence of menstrual cycle; black, tarry stools; chest pain; fainting; fast, slow, or irregular heartbeat; headache; loose or bloody stools; pain, redness, burning, stinging, swelling, or open sores at the injection site; rectal bleeding or irritation; redness or discharge of the eyes; redness, pain, swelling, peeling, tingling, or blistering of the palms of the hands and the soles of the feet; severe or persistent nausea or vomiting; shortness of breath; sudden, unexplained weight gain; swelling of the hands, ankles, or feet; swelling or soreness of the mouth or tongue; symptoms of dehydration (eg, dry mouth or eyes, decreased urination, fast heartbeat, sluggishness, unusual thirst); symptoms of infection (eg, fever, chills, cough, sore throat, burning or painful urination); unusual bruising or bleeding; unusual tiredness or weakness; vomiting.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include swelling or soreness of the mouth or tongue; unusual bruising or bleeding.
Doxorubicin is usually handled and stored by a health care provider. If you are using Doxorubicin at home, store Doxorubicin as directed by your pharmacist or health care provider. Keep Doxorubicin out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Doxorubicin. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Xerese is a brand name of acyclovir/hydrocortisone topical, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Xerese available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xerese. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Ap Inyect Solucion Cloruro Potasico may be available in the countries listed below.
Potassium Chloride is reported as an ingredient of Ap Inyect Solucion Cloruro Potasico in the following countries:
International Drug Name Search
Gastirol may be available in the countries listed below.
Tiquizium Bromide is reported as an ingredient of Gastirol in the following countries:
International Drug Name Search
Peptidin may be available in the countries listed below.
Omeprazole is reported as an ingredient of Peptidin in the following countries:
International Drug Name Search
Prilagin may be available in the countries listed below.
Miconazole is reported as an ingredient of Prilagin in the following countries:
Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Prilagin in the following countries:
International Drug Name Search
Rinderon-A may be available in the countries listed below.
Betamethasone 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Rinderon-A in the following countries:
Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Rinderon-A in the following countries:
International Drug Name Search
Sanfloks may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Sanfloks in the following countries:
International Drug Name Search
Flupamid-SR may be available in the countries listed below.
Indapamide is reported as an ingredient of Flupamid-SR in the following countries:
International Drug Name Search
Nicardipine Aguettant may be available in the countries listed below.
Nicardipine hydrochloride (a derivative of Nicardipine) is reported as an ingredient of Nicardipine Aguettant in the following countries:
International Drug Name Search
Licodin may be available in the countries listed below.
Ticlopidine is reported as an ingredient of Licodin in the following countries:
International Drug Name Search
Lo-Lyndiol may be available in the countries listed below.
Lynestrenol is reported as an ingredient of Lo-Lyndiol in the following countries:
Mestranol is reported as an ingredient of Lo-Lyndiol in the following countries:
International Drug Name Search
Adsorbin may be available in the countries listed below.
Aluminium Silicate is reported as an ingredient of Adsorbin in the following countries:
International Drug Name Search
Flubendazol may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Flubendazole is reported as an ingredient of Flubendazol in the following countries:
International Drug Name Search
